Active Not Recruiting OBSERVATIONAL NCT05481242

An Observational Study About Adverse Outcomes in Acute Pulmonary Embolism Patients

Sponsor: Shengjing Hospital

Conditions Deterioration, Clinical Pulmonary Embolism and Thrombosis

Interventions retrospective observational study

Updated 6 times since 2022 Last updated: Mar 8, 2026 Started: Jan 1, 2011 Primary completion: Jan 31, 2021 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05481242, this observational or N/A phase trial focuses on Deterioration, Clinical and Pulmonary Embolism and Thrombosis and remains ongoing. Sponsored by Shengjing Hospital, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Mar 2026 — Present [monthly]

Active Not Recruiting

Status: Unknown → Active Not Recruiting
Feb 2026 — Mar 2026 [monthly]

Unknown

Status: Active Not Recruiting → Unknown
Sep 2024 — Feb 2026 [monthly]

Active Not Recruiting
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting
Dec 2023 — Jul 2024 [monthly]

Active Not Recruiting

Status: Recruiting → Active Not Recruiting

▶ Show 1 earlier version

Sep 2022 — Dec 2023 [monthly]

Recruiting

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shengjing Hospital

Data source: Shengjing Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shenyang, China